Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475

Clinical trial NCT03049618 · COMPLETED

Trial details

NCT number: NCT03049618
Sponsor: University of Southern California
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

ALK Gene Mutation BRAF Gene Mutation EGFR Gene Mutation Head and Neck Squamous Cell Carcinoma Metastatic Head and Neck Carcinoma Recurrent Head and Neck Carcinoma Recurrent Non-Small Cell Lung Carcinoma ROS1 Gene Mutation Stage III Non-Small Cell Lung Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer

Start date: 2017-03-10
Primary completion: 2024-09-04
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.